메뉴 건너뛰기




Volumn 37, Issue 3, 2014, Pages 421-429

A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTANOL; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CYP27A1 PROTEIN, HUMAN;

EID: 84904178027     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9674-3     Document Type: Article
Times cited : (110)

References (40)
  • 1
    • 0033693277 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis: The spectrum of imaging findings and the correlation with neuropathologic findings
    • Barkhof F, Verrips A, Wesseling P et al (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217:869-876
    • (2000) Radiology , vol.217 , pp. 869-876
    • Barkhof, F.1    Verrips, A.2    Wesseling, P.3
  • 2
    • 0021784183 scopus 로고
    • Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography
    • Batta AK, Shefer S, Batta M, Salen G (1985) Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. J Lipid Res 26:690-698 (Pubitemid 15248941)
    • (1985) Journal of Lipid Research , vol.26 , Issue.6 , pp. 690-698
    • Batta, A.K.1    Shefer, S.2    Batta, M.3    Salen, G.4
  • 3
    • 0021707122 scopus 로고
    • Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid
    • Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649-1652 (Pubitemid 15183994)
    • (1984) New England Journal of Medicine , vol.311 , Issue.26 , pp. 1649-1652
    • Berginer, V.M.1    Salen, G.2    Shefer, S.3
  • 5
    • 59449087114 scopus 로고    scopus 로고
    • Chronic diarrhea and juvenile cataracts: Think cerebrotendinous xanthomatosis and treat
    • Berginer VM, Gross B, Morad K et al (2009) Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat. Pediatrics 123:143-147
    • (2009) Pediatrics , vol.123 , pp. 143-147
    • Berginer, V.M.1    Gross, B.2    Morad, K.3
  • 6
    • 77952304021 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis: An inborn error in bile acid synthesis with defined mutations but still a challenge
    • Björkhem I, Hansson M (2010) Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem Biophys Res Commun 396:46-49
    • (2010) Biochem Biophys Res Commun , vol.396 , pp. 46-49
    • Björkhem, I.1    Hansson, M.2
  • 7
    • 0025868097 scopus 로고
    • Characterization of human sterol 27-hydroxylase: A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis
    • Cali JJ, Russell DW (1991) Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 266:7774-7778 (Pubitemid 21906433)
    • (1991) Journal of Biological Chemistry , vol.266 , Issue.12 , pp. 7774-7778
    • Cali, J.J.1    Russell, D.W.2
  • 8
    • 12244306965 scopus 로고    scopus 로고
    • Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis
    • DOI 10.1023/A:1021211520034
    • Clayton PT, Verrips A, Sistermans E, Mann A, Mieli-Vergani G, Wevers R (2002) Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis 25:501-513 (Pubitemid 36104385)
    • (2002) Journal of Inherited Metabolic Disease , vol.25 , Issue.6 , pp. 501-513
    • Clayton, P.T.1    Verrips, A.2    Sistermans, E.3    Mann, A.4    Mieli-Vergani, G.5    Wevers, R.6
  • 9
    • 64449083900 scopus 로고    scopus 로고
    • Children with cataract and chronic diarrhoea: Cerebrotendinous xanthomatosis
    • Cruysberg JR (2009) Children with cataract and chronic diarrhoea: cerebrotendinous xanthomatosis. J Inherit Metab Dis 32:309
    • (2009) J Inherit Metab Dis , vol.32 , pp. 309
    • Cruysberg, J.R.1
  • 10
    • 0025936676 scopus 로고
    • Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis
    • Cruysberg JR, Wevers RA, Tolboom JJ (1991) Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol 112:606-607
    • (1991) Am J Ophthalmol , vol.112 , pp. 606-607
    • Cruysberg, J.R.1    Wevers, R.A.2    Tolboom, J.J.3
  • 11
    • 0035188015 scopus 로고    scopus 로고
    • Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis
    • De Stefano N, Dotti MT, Mortilla M, Federico A (2001) Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 124:121-131 (Pubitemid 32055994)
    • (2001) Brain , vol.124 , Issue.1 , pp. 121-131
    • De Stefano, N.1    Dotti, M.T.2    Mortilla, M.3    Federico, A.4
  • 13
    • 0141997295 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis: Clinical manifestations, diagnostic criteria, pathogenesis, and therapy
    • Federico A, Dotti MT (2003) Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 18:633-638 (Pubitemid 37258469)
    • (2003) Journal of Child Neurology , vol.18 , Issue.9 , pp. 633-638
    • Federico, A.1    Dotti, M.T.2
  • 14
    • 84901887818 scopus 로고    scopus 로고
    • Psychiatric manifestations in cerebrotendinous xanthomatosis
    • doi:10.1038/tp.2013.76
    • Fraidakis MJ (2013) Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry 3:e302. doi:10.1038/tp.2013.76
    • (2013) Transl Psychiatry , vol.3
    • Fraidakis, M.J.1
  • 15
    • 84872362010 scopus 로고    scopus 로고
    • Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid
    • Ginanneschi F, Mignarri A, Mondelli M et al (2013) Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol 260:268-274
    • (2013) J Neurol , vol.260 , pp. 268-274
    • Ginanneschi, F.1    Mignarri, A.2    Mondelli, M.3
  • 16
    • 0022347684 scopus 로고
    • Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis
    • DOI 10.1016/0009-8981(85)90182-2
    • Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ (1985) Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Clin Chim Acta 152:115-122 (Pubitemid 16233196)
    • (1985) Clinica Chimica Acta , vol.152 , Issue.1-2 , pp. 115-122
    • Koopman, B.J.1    Wolthers, B.G.2    Van Der, M.J.C.3    Waterreus, R.J.4
  • 18
    • 25144451226 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis: Possible higher prevalence than previously recognized
    • DOI 10.1001/archneur.62.9.1459
    • Lorincz MT, Rainier S, Thomas D, Fink JK (2005) Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol 62:1459-1463 (Pubitemid 41352065)
    • (2005) Archives of Neurology , vol.62 , Issue.9 , pp. 1459-1463
    • Lorincz, M.T.1    Rainier, S.2    Thomas, D.3    Fink, J.K.4
  • 19
    • 84873744151 scopus 로고    scopus 로고
    • Long-term bone density evaluation in cerebrotendinous xanthomatosis: Evidence of improvement after chenodeoxycholic acid treatment
    • Martini G, Mignarri A, Ruvio M et al (2013) Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int 92:282-286
    • (2013) Calcif Tissue Int , vol.92 , pp. 282-286
    • Martini, G.1    Mignarri, A.2    Ruvio, M.3
  • 20
    • 79960029352 scopus 로고    scopus 로고
    • Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis
    • Mignarri A, Rossi S, Ballerini M et al (2011) Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis. J Neurol 258:783-790
    • (2011) J Neurol , vol.258 , pp. 783-790
    • Mignarri, A.1    Rossi, S.2    Ballerini, M.3
  • 21
    • 84862862497 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: Six-year MRI follow-up
    • Mignarri A, Dotti MT, Del Puppo M et al (2012a) Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: six-year MRI follow-up. Neuroradiology 54:649-651
    • (2012) Neuroradiology , vol.54 , pp. 649-651
    • Mignarri, A.1    Dotti, M.T.2    Del Puppo, M.3
  • 22
    • 84655161937 scopus 로고    scopus 로고
    • Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis
    • Mignarri A, Falcini M, Vella A et al (2012b) Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis. Parkinsonism Relat Disord 18:99-101
    • (2012) Parkinsonism Relat Disord , vol.18 , pp. 99-101
    • Mignarri, A.1    Falcini, M.2    Vella, A.3
  • 23
    • 0025895604 scopus 로고
    • Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis
    • Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S (1991) Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism 40:741-746
    • (1991) Metabolism , vol.40 , pp. 741-746
    • Nakamura, T.1    Matsuzawa, Y.2    Takemura, K.3    Kubo, M.4    Miki, H.5    Tarui, S.6
  • 26
    • 80052806070 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis in Spain: Clinical, prognostic, and genetic survey
    • Pilo de la Fuente B, Jimenez-Escrig A, Lorenzo JR et al (2011a) Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol 18:1203-1211
    • (2011) Eur J Neurol , vol.18 , pp. 1203-1211
    • Pilo De La Fuente, B.1    Jimenez-Escrig, A.2    Lorenzo, J.R.3
  • 27
    • 79961166408 scopus 로고    scopus 로고
    • Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis
    • Pilo de la Fuente B, Sobrido MJ, Girós M et al (2011b) Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis. Neurologia 26:397-404
    • (2011) Neurologia , vol.26 , pp. 397-404
    • Pilo De La Fuente, B.1    Sobrido, M.J.2    Girós, M.3
  • 28
    • 79953049062 scopus 로고    scopus 로고
    • Neurophysiological study in cerebrotendinous xanthomatosis
    • Pilo B, de Blas G, Sobrido MJ et al (2011) Neurophysiological study in cerebrotendinous xanthomatosis. Muscle Nerve 43:531-536
    • (2011) Muscle Nerve , vol.43 , pp. 531-536
    • Pilo, B.1    De Blas, G.2    Sobrido, M.J.3
  • 29
    • 84871793065 scopus 로고    scopus 로고
    • Atypical parkinsonism and cerebrotendinous xanthomatosis: Report of a family with corticobasal syndrome and a literature review
    • Rubio-Agusti I, Kojovic M, Edwards MJ et al (2012) Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review. Mov Disord 27:1769-1774
    • (2012) Mov Disord , vol.27 , pp. 1769-1774
    • Rubio-Agusti, I.1    Kojovic, M.2    Edwards, M.J.3
  • 30
    • 0023265331 scopus 로고
    • Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid
    • Salen G, Berginer V, Shore V et al (1987) Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. N Engl J Med 316:1233-1238 (Pubitemid 17069352)
    • (1987) New England Journal of Medicine , vol.316 , Issue.20 , pp. 1233-1238
    • Salen, G.1    Berginer, V.2    Shore, V.3
  • 31
    • 0028075336 scopus 로고
    • Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis
    • DOI 10.1016/0026-0495(94)90183-X
    • Salen G, Batta AK, Tint GS, Shefer S (1994) Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. Metabolism 43:1018-1022 (Pubitemid 24249405)
    • (1994) Metabolism: Clinical and Experimental , vol.43 , Issue.8 , pp. 1018-1022
    • Salen, G.1    Batta, A.K.2    Tint, G.S.3    Shefer, S.4
  • 32
    • 85086351538 scopus 로고    scopus 로고
    • Chenodeoxycholic treatment of cerebrotendinous xanthomatosis
    • Samenuk P, Koffman BM (2001) Chenodeoxycholic treatment of cerebrotendinous xanthomatosis. Neurology 56:695-696
    • (2001) Neurology , vol.56 , pp. 695-696
    • Samenuk, P.1    Koffman, B.M.2
  • 33
    • 33645090933 scopus 로고    scopus 로고
    • Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    • Siman-Tov T, Meiner V, Gadoth N (2006) Could steroids mask the diagnosis of cerebrotendinous xanthomatosis? J Neurol Sci 243:83-86
    • (2006) J Neurol Sci , vol.243 , pp. 83-86
    • Siman-Tov, T.1    Meiner, V.2    Gadoth, N.3
  • 34
    • 77949519798 scopus 로고    scopus 로고
    • Cerebrotendinous xanthomatosis patients with and without parkinsonism: Clinical characteristics and neuroimaging findings
    • Su CS, Chang WN, Huang SH et al (2010) Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord 25:452-458
    • (2010) Mov Disord , vol.25 , pp. 452-458
    • Su, C.S.1    Chang, W.N.2    Huang, S.H.3
  • 40
    • 84878827771 scopus 로고    scopus 로고
    • Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: Early versus late diagnosis
    • Yahalom G, Tsabari R, Molshatzki N, Ephraty L, Cohen H, Hassin-Baer S (2013) Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: early versus late diagnosis. Clin Neuropharmacol 36:78-83
    • (2013) Clin Neuropharmacol , vol.36 , pp. 78-83
    • Yahalom, G.1    Tsabari, R.2    Molshatzki, N.3    Ephraty, L.4    Cohen, H.5    Hassin-Baer, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.